People: Agios Pharmaceuticals Inc (AGIO.OQ)

AGIO.OQ on NASDAQ Stock Exchange Global Select Market

1:30am IST
Change (% chg)

$-1.13 (-3.00%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Oliveira, Orlando 

Mr. Orlando Oliveira is Senior Vice President, General Manager, International of the Company. Prior to Agios, Mr. Oliveira served as senior vice president and general manager, international at TESARO from September 2015 to June 2019 where, as its first international employee, he headed the build out of the company's EU presence and lead the approval, reimbursement and multiple successful country launches of two oncology drugs, Varuby ® (rolapitant) and ZEJULA ® (niraparib), across key international markets. Before TESARO, Mr. Oliveira was vice president, Europe and intercontinental operations at Cubist Pharmaceuticals, where he led a team of executives that managed 19 countries across Europe, Canada, and Australia and was responsible for all alliances within Cubist covering Japan, China, LATAM, and the MENA regions. Previously, Mr. Oliveira held several positions at Amgen, including country leadership roles in Portugal and Mexico, and international oncology marketing roles first as head of oncology in the Nordic region and head of the international filgrastim franchise based in Switzerland. He began his career in sales at Johnson & Johnson. Mr. Oliveira earned his pharmacy degree from the University of Coimbra, Portugal.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --